Bleomycin sclerotherapy for large diffuse microcystic lymphatic malformations.

Gland Surg

Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Published: June 2021

Background: Microcystic lymphatic malformations (LMs) are congenital lesions with the diameter of the majority of cysts <1 cm. Bleomycin sclerotherapy has been shown to yield beneficial results for macrocystic LMs. This study aims to evaluate the safety and efficacy of consecutive bleomycin sclerotherapy for large diffuse microcystic LMs.

Methods: The location and size of the lesions were detected by ultrasound for the 46 patients included in this study. Bleomycin lavage was performed in larger cysts and intradermal injection for the superficial lesion. The outcome and complications were assessed for its efficacy and safety.

Results: The large diffuse microcystic LMs mainly located in the neck, abdominal wall and axilla/lateral chest wall. The average lesion size was 10.6 cm × 7.2 cm. The mean number of treatment sessions was 4.5 with 7.3 mg bleomycin for per session averagely. Excellent (69.6%) and moderate (23.9%) responses were obtained. There was no recurrence for the 6 patients (13%) who received a long follow-up. Obvious local swelling, slight intralesional hemorrhage and low-grade fever were the most commonly occurred complications. No lung fibrosis was identified for the patients who received more than 6 sessions.

Conclusions: Local lavage combined with intradermal injection of bleomycin is effective and safe for large diffuse microcystic LMs with good therapeutic effect and low complication rates, and can be regarded as the mainstay of therapy for microcystic LMs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258892PMC
http://dx.doi.org/10.21037/gs-21-70DOI Listing

Publication Analysis

Top Keywords

microcystic lymphatic
8
lymphatic malformations
8
bleomycin sclerotherapy
4
sclerotherapy large
4
large diffuse
4
diffuse microcystic
4
malformations background
4
background microcystic
4
malformations lms
4
lms congenital
4

Similar Publications

Background: Lymphatic malformations (LMs) are low-flow, congenital lesions commonly presenting as asymptomatic masses in the head and neck. However, large lymphangiomas can significantly affect breathing or swallowing, posing considerable treatment challenges.

Methods: A retrospective analysis of complex cervicofacial LMs in infants was conducted over the past 8 years at the Department of Radiology.

View Article and Find Full Text PDF

Background: Over the past few decades, percutaneous sclerotherapy has been proven to be efficacy in treating macrocystic lymphatic malformations (LMs). Unfortunately, there still remains challenging in the treatment of microcystic LMs given their size. We introduce the intralesional laser thermolysis (ILT) technique, a novel enhancement technique for the traditional percutaneous sclerotherapy in the treatment of microcystic LMs.

View Article and Find Full Text PDF

Objective: Examine the management and outcomes of pediatric head and neck lymphatic malformations (HNLMs).

Study Design: Retrospective case series.

Setting: Tertiary academic hospital.

View Article and Find Full Text PDF

Hamartomatous lymphatic channel proliferation causes lymphangiomas or microcystic lymphatic malformations (MLM). They are most commonly found in the head and neck, with oral occurrences a rarity. In this case, a 34-year-old woman presented with lymphangioma circumscriptum on the buccal mucosa, a condition that typically causes asymptomatic pebbly papules.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the MELF invasion pattern in endometrioid endometrial cancer (EEC) to understand its clinical, pathological, and molecular features, as well as its impact on patient prognosis.
  • Data from 342 EEC patients showed that the MELF pattern is more common in low-grade tumors and is linked to advanced disease indicators like FIGO staging, lymph node metastasis, and certain molecular biomarkers, including higher rates of mismatch-repair-deficient proteins.
  • While recurrence risk did not differ significantly between patients with and without the MELF pattern, those with MELF experienced shorter recurrence times, highlighting the need for further research on its implications for treatment and patient outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!